Susquehanna International Group’s Tenaya Therapeutics TNYA Stock Holding History

Susquehanna International Group’s Portfolio TNYA Stock Details TNYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$37.2K	Buy	53,900 +2,600	+5%	+$1.92K	﹤0.01%	12710
2025 Q4	$36.4K	Buy	51,300 +2,200	+4%	+$2.99K	﹤0.01%	11841
2025 Q3	$79.5K	Buy	49,100 +25,900	+112%	+$26.1K	﹤0.01%	11681
2025 Q2	$14.2K	Buy	+23,200	New	+$11.8K	﹤0.01%	12376
2025 Q1	–	Sell	-103,400	Closed	-$148K	–	13467
2024 Q4	$148K	Buy	+103,400	New	+$232K	﹤0.01%	11030
2023 Q3	–	Sell	-10,000	Closed	-$58.7K	–	12989
2023 Q2	$58.7K	Sell	10,000 -11,300	-53%	-$65.7K	﹤0.01%	11266
2023 Q1	$60.7K	Buy	+21,300	New	+$59.9K	﹤0.01%	11604

Other funds holding TNYA

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BGM

Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $141M AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's TNYA Position: Q1 2026 in Review

Susquehanna International Group increased its Tenaya Therapeutics (TNYA) stake by 8.5% in Q1 2026, buying an estimated $17.8K and bringing the position to 308,772 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #11556.

Susquehanna International Group first reported a position in TNYA in Q4 2022 and has held it in 13 quarters since. The position peaked at $575K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

Susquehanna International Group held 308,772 shares of Tenaya Therapeutics worth $214K as of Q1 2026.
Susquehanna International Group bought 24,185 Tenaya Therapeutics shares in Q1 2026, an estimated $17.8K.
Tenaya Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11556 holding.
Susquehanna International Group first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 13 quarters since.
Susquehanna International Group's Tenaya Therapeutics position peaked at $575K in Q3 2025.
103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.